NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
Open accessThe DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
Abstract
Schizophrenia is a disabling mental illness that is now recognized as a neurodevelopmental disorder. It is likely that genetic risk factors interact with environmental perturbations to affect normal brain development and that this altered trajectory results in a combination of positive, negative, and cognitive symptoms. Although the exact pathophysiology of schizophrenia is unknown, the N-methyl-D-aspartate receptor (NMDAR), a major glutamate receptor subtype, has received great attention. Proper expression and regulation of NMDARs in the brain is critical for learning and memory processes as well as cortical plasticity and maturation. Evidence from both animal models and human studies implicates a dysfunction of NMDARs both in disease progression and symptoms of schizophrenia. Furthermore, mutations in many of the known genetic risk factors for schizophrenia suggest that NMDAR hypofunction is a convergence point for schizophrenia. In this review, we discuss how disrupted NMDAR function leads to altered neurodevelopment that may contribute to the progression and development of symptoms for schizophrenia, particularly cognitive deficits. We review the shared signaling pathways among the schizophrenia susceptibility genes DISC1, neuregulin1, and dysbindin, focusing on the AKT/GSK3β pathway, and how their mutations and interactions can lead to NMDAR dysfunction during development. Additionally, we explore what open questions remain and suggest where schizophrenia research needs to move in order to provide mechanistic insight into the cause of NMDAR dysfunction, as well as generate possible new avenues for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Enhanced Polyubiquitination of Shank3 and NMDA Receptor in a Mouse Model of Autism
Bangash, M. A., Park, J. M., Melnikova, T., Wang, D., Jeon, S. K., Lee, D., Syeda, S., Kim, J., Kouser, M., Schwartz, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.052 · Cited by 114 · cited 1×
“For example, downregulation of synaptic NR1 has been associated with polyubiquitination (Groblewski and Stafford, 2010; Bangash et al., 2011).”
RetractedDNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124 · cited 1×
“In general, increasing DNA methylation, particularly at CpG islands of promoter sequences, will decrease gene expression (Bird, 2002).”
BackgroundThe adolescent brain and age-related behavioral manifestations
Spear, L. P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00014-2 · Cited by 5,433 · cited 2×
“The NMDAR subunit shift therefore marks the transition from juvenile to “adult” neural processing (Dumas, 2005; Henson et al., 2010) and the subunit switch makes the NMDARs extremely vulnerable to genetic and environmental risk factors (Spear, 2000).”
BackgroundImplications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724 · cited 1×
“…NEURODEVELOPMENTAL DISORDER WITH MULTIPLE SUSCEPTIBILITY GENES CONVERGING ON NMDARs It is increasingly recognized that schizophrenia is a neurodevelopmental disorder that involves disrupted alterations in brain circuits (Weinberger, 1987; Lewis and Gonzalez-Burgos, 2008; Jaaro-Peled et al., 2009).”
BackgroundMonyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · cited 2×
“REVIEW ARTICLE published: 27 March 2013 doi: 10.3389/fncel.2013.00031 NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia”
BackgroundInfluentialRecent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904 · cited 1×
“Second, NMDAR antagonists, such as phencyclidine (PCP), dizocilpine (MK-801), and ketamine, produce “schizophrenia like” symptoms in healthy individuals (Javitt and Zukin, 1991; Krystal et al., 1994; Lahti et al., 1995).”
BackgroundThe Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · cited 4×
“It is likely that convergent mechanisms target NMDAR, which in turn contribute to negative symptoms and neurocognitive dysfunction directly (Lau and Zukin, 2007), as well as to positive symptoms via dysregulation of brain DA systems indirectly (Howes and Kapur, 2009; Abi-Dargham, 2012).”
BackgroundInfluentialHeteromeric NMDA receptors: molecular and functional distinction of subtypes
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541 · cited 1×
“Moreover, the NR2 subunit’s large C-terminus has many putative sites for phosphorylation which can affect channel gating and stabilization at the synapse (Monyer et al., 1992; Kornau et al., 1995).”
BackgroundCortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · cited 2×
“…neurons also interact with other neurons that have been strongly implicated in the pathophysiology of schizophrenia, including morphologically altered GABAergic interneurons (Lewis et al., 2005) and antipsychotic drug-targeted DA neurons (Howes and Kapur, 2009; Abi-Dargham, 2012; Grace, 2012).”
Background
Cited by
The Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease
Berridge, M. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00006.2016 · Cited by 753
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
Hussain, G., Rasul, A., Anwar, H., Aziz, N., Razzaq, A., Wei, W., Ali, M., Li, J., & Li, X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23247 · Cited by 351
The Gut-Brain Axis, BDNF, NMDA and CNS Disorders
Maqsood, R., & Stone, T. W. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2039-1 · Cited by 222
The neurobiology and treatment of first-episode schizophrenia
Kahn, R. S., & Sommer, I. E. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.66 · Cited by 219
Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia
Berridge, M. J. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1806-z · Cited by 181
“This defect in the ability of the NMDARs on the inhibitory interneurons to respond to glutamate is the basis of the NMDAR hypofunction hypothesis of schizophrenia (Coyle 2006; Kantrowitz and Javitt 2010; Nakazawa et al. 2012; Snyder and Gao 2013).”
BackgroundCattane, N., Rossi, R., Lanfredi, M., & Cattaneo, A. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1383-2 · Cited by 169
“Glutamatergic and N-methyl-D-aspartate (NMDA) neurotransmissions play a critical role in neurodevelopment, synaptic plasticity, learning and memory [33, 34] and alterations in all these processes have been involved also in the vulnerability and pathophysiology of BPD [35].”
BackgroundFerguson, B. R., & Gao, W.-J. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.01027 · Cited by 75
“, 2008, 2013), as well as being linked to cognitive dysfunction in schizophrenia (Snyder and Gao, 2013).”
Self-citationGuidi, M., Kumar, A., & Foster, T. C. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3523-14.2015 · Cited by 63
“An interaction of redox state and NMDAR hypofunction is thought to contribute to mental disorders such as schizophrenia (Steullet et al., 2006; Snyder and Gao, 2013; X. Wang et al., 2013).”
BackgroundGulchina, Y., Xu, S., Snyder, M. A., Elefant, F., & Gao, W. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14101 · Cited by 56
Self-citationShaw, A. D., Knight, L., Freeman, T. C. A., Williams, G. M., Moran, R. J., Friston, K. J., Walters, J. T. R., & Singh, K. D. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz066 · Cited by 54
“In conclusion, these results establish—for the first time—a 4-way construct validity between (1) a visual psychophysical test dependent on local gain control, (2) a noninvasive synaptic assay (DCM), (3) a neurotransmitter deficit (GABA MRS), and (4) the functional anatomy of SZ (in terms of dysconnectivity that speaks…”
ResultIonotropic glutamate receptors: Which ones, when, and where in the mammalian neocortex
Hadzic, M., Jack, A., & Wahle, P. (2017) · Journal of Comparative Neurology · doi:10.1002/cne.24103 · Cited by 53
Gos, T., Myint, A.-M., Schiltz, K., Meyer-Lotz, G., Dobrowolny, H., Busse, S., Müller, U. J., Mawrin, C., Bernstein, H.-G., Bogerts, B., et al. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.05.012 · Cited by 49
“These alterations may induce dopaminergic hyperactivity that may be a primary factor for the emergence of positive symptoms in schizophrenia, such as delusions and hallucinations (Lisman et al., 2008; Snyder and Gao, 2013).”
Background22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis
Squarcione, C., Torti, M. C., Di Fabio, F., & Biondi, M. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s52188 · Cited by 46
“is encoded by DLG4 [discs, large homolog 4]), are known to be regulated dynamically through palmitoylation.(97,98,103)”
Causes of Sudden Unexpected Death in Schizophrenia Patients: A Forensic Autopsy Population Study
Sun, D., Li, L., Zhang, X., Blanchard, T. G., Fowler, D. R., & Li, L. (2019) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000000512 · Cited by 30
“schizophrenia with cardiac deaths have been identified, such as Neuregulin 116,25–28 and the N-methyl-D-aspartate.28 A common missense variant in the Neuregulin 1 gene (SNP rs10503929), for example, is recently reported to be associated with both conditions.16 Impaired social interaction may also be a contributing fac…”
BackgroundO’Tuathaigh, C. M. P., Fumagalli, F., Desbonnet, L., Perez-Branguli, F., Moloney, G., Loftus, S., O’Leary, C., Petit, E., Cox, R., Tighe, O., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw120 · Cited by 22
Berndt, L. C. S., Singh, K. D., & Shaw, A. D. (2026) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf149 · Cited by 3
Metadata
- Authors
- Snyder, M. A., & Gao, W.-J.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 7
- Pages
- 31-31
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2145728950
- Cited by
- 236
- References
- 204
- FWCI
- 17.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.